{"id":"https://openalex.org/W2532997430","doi":"https://doi.org/10.1182/blood.v104.11.4820.4820","title":"Synergy between CD52 and CD20 Antibody-Induced Apoptosis Correlates with the Extent of Co-Expression of CD20 and CD52 Antigens on Mononuclear Cells Derived from Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin\u2019s Lymphoma (NHL) Patients: Implications to Antibody-Based Therapy.","display_name":"Synergy between CD52 and CD20 Antibody-Induced Apoptosis Correlates with the Extent of Co-Expression of CD20 and CD52 Antigens on Mononuclear Cells Derived from Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin\u2019s Lymphoma (NHL) Patients: Implications to Antibody-Based Therapy.","publication_year":2004,"publication_date":"2004-11-16","ids":{"openalex":"https://openalex.org/W2532997430","doi":"https://doi.org/10.1182/blood.v104.11.4820.4820","mag":"2532997430"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v104.11.4820.4820","doi":"https://doi.org/10.1182/blood.v104.11.4820.4820","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.4820.4820","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091722266","display_name":"Yair Gazitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yair Gazitt","raw_affiliation_strings":["Medicine, University of Texas Health Science Center, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, University of Texas Health Science Center, San Antonio, TX, USA","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056435509","display_name":"Cagla Akay","orcid":"https://orcid.org/0000-0003-0199-3836","observed_orcids":["https://orcid.org/0000-0003-0199-3836"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cagla Akay","raw_affiliation_strings":["Medicine, University of Texas Health Science Center, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, University of Texas Health Science Center, San Antonio, TX, USA","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046450410","display_name":"Deborah L. Doxey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deborah Doxey","raw_affiliation_strings":["Berlex, Seattle, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Berlex, Seattle, TX, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109861002","display_name":"Charles A. Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Thomas","raw_affiliation_strings":["Medicine, University of Texas Health Science Center, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, University of Texas Health Science Center, San Antonio, TX, USA","institution_ids":["https://openalex.org/I165951966"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.33900486,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"104","issue":"11","first_page":"4820","last_page":"4820"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd52","display_name":"CD52","score":0.9909999966621399},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9319999814033508},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9599999785423279},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":0.7929999828338623},{"id":"https://openalex.org/keywords/antigen-expression","display_name":"antigen expression","score":0.4580000042915344},{"id":"https://openalex.org/keywords/mononuclear-cells","display_name":"mononuclear cells","score":0.7680000066757202},{"id":"https://openalex.org/keywords/antibody-based-therapy","display_name":"antibody-based therapy","score":0.7139999866485596},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5849999785423279},{"id":"https://openalex.org/keywords/mean-fluorescence-intensity","display_name":"mean fluorescence intensity","score":0.6359999775886536},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.48399999737739563},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"bone marrow","score":0.41499999165534973},{"id":"https://openalex.org/keywords/peripheral-blood","display_name":"peripheral blood","score":0.8960000276565552}],"concepts":[{"id":"https://openalex.org/C2778384904","wikidata":"https://www.wikidata.org/wiki/Q21108353","display_name":"CD52","level":4,"score":0.9499368667602539},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.8079155087471008},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7101648449897766},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5910212397575378},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5303825736045837},{"id":"https://openalex.org/C159912055","wikidata":"https://www.wikidata.org/wiki/Q14885119","display_name":"CD38","level":4,"score":0.5282527208328247},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.526365339756012},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5050740838050842},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.48084744811058044},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4254900813102722},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.42505767941474915},{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.3919540345668793},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3675788342952728},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.14211291074752808},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13238665461540222},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0836142897605896},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v104.11.4820.4820","doi":"https://doi.org/10.1182/blood.v104.11.4820.4820","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.4820.4820","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8199999928474426,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2082620902","https://openalex.org/W2938848712","https://openalex.org/W2081737680","https://openalex.org/W2554558313","https://openalex.org/W2164294729","https://openalex.org/W2160420564","https://openalex.org/W2129358485","https://openalex.org/W1783223960","https://openalex.org/W2013265163","https://openalex.org/W1972907139"],"abstract_inverted_index":{"Abstract":[0],"CD20":[1,118,281,324,346,376,409,474,483,531],"(Rituximab)":[2],"and":[3,17,119,132,142,188,203,237,243,250,269,275,286,291,294,299,311,317,325,333,347,353,363,377,392,407,425,438,455,475,484,489,502,515,530],"CD52":[4,120,395,460,463,476,485,519,529],"(Campath":[5],"1-H)":[6],"antibodies":[7],"(Abs)":[8],"have":[9],"been":[10,30,43,154],"employed":[11],"in":[12,24,32,46,159,221,272,288,308,396,411,487,500],"the":[13,67,71,91,96,111,233,258,511,526],"treatment":[14,72,410],"of":[15,51,73,93,95,117,150,164,184,215,223,245,306,418,434,451,469,473,495,513,528],"NHL":[16,33,58,76,201,274,290,310,357,383,397,412,426,488,503],"CLL":[18,47,74,160,169,186,276,312,341,368,402,424,490,501],"pts,":[19,34,59,277],"as":[20],"single":[21],"agents":[22],"or":[23,75,218,453,461,520],"combination":[25,417,494],"with":[26,35,49,53,61,66,107,156,213,240],"chemotherapy.":[27],"Rituximab":[28],"has":[29,42,153],"effective":[31,45],">50%":[36],"response":[37,536],"rate":[38],"(RR).":[39],"Campath":[40],"1-H":[41],"less":[44],"pts":[48,77,170,187,202,313,342,358,369,384,398,403,413,427],"RR":[50],"~30%":[52],"similar":[54],"results":[55],"observed":[56,389],"for":[57,70,102,328,394,401,408,423,479,525,534],"but":[60],"increased":[62,421],"toxicity.":[63],"Combination":[64],"therapy":[65,87],"two":[68],"Abs":[69,113,220,327,349,486,497],"was":[78,134,171,207,230,238,283,314,330,350,360,388,436,440,447,508],"not":[79],"attempted.":[80],"We":[81],"hypothesized":[82],"that":[83],"responsiveness":[84],"to":[85,374,537],"Ab-based":[86,538],"will":[88],"depend":[89],"on":[90,99,122,166],"extent":[92,468],"expression":[94,163,242,282,433,450,470,512,527],"relevant":[97],"antigen":[98,152],"cancer":[100],"cells":[101,124,141],"each":[103],"disease":[104,157],"category":[105],"resulting":[106],"a":[108],"synergy":[109],"when":[110],"2":[112],"were":[114,126,147,177,197,262,296,370],"combined.":[115],"Expression":[116,149],"antigens":[121],"mononuclear":[123],"(MNCs)":[125],"determined":[127,172,231],"by":[128,136,173,209,232,322,344,458,482,517],"2-color":[129],"immunofluorescence":[130],"staining":[131],"analysis":[133],"done":[135],"flow":[137],"cytometry.":[138],"Percent":[139],"positive":[140],"mean":[143],"fluorescence":[144,265],"intensities":[145],"(MFI)":[146],"determined.":[148],"CD38":[151,165,435,452,514],"correlated":[155,239],"outcome":[158],"pts.":[161],"The":[162,416,467,493],"MNCs":[167,183,196,366,381],"from":[168,179,199,367,382],"3-color":[174],"taining.":[175],"Samples":[176],"obtained":[178,198],"peripheral":[180],"blood":[181],"(PB)":[182],"17":[185],"10":[189,204],"healthy":[190],"donors":[191],"(HD).":[192],"Bone":[193],"marrow":[194],"(BM)":[195],"35":[200],"HD.":[205],"Apoptosis":[206,229],"induced":[208,457],"24":[210],"hour":[211],"culture":[212],"1ug/ml":[214],"CD20,":[216,459,518],"CD52,":[217,323,345,375],"CD52+CD20":[219,326,348],"1ml":[222],"medium":[224],"containing":[225],"1":[226],"million":[227],"MNCs.":[228,491,504],"Annexin":[234],"V":[235],"method":[236],"%":[241,280,304,432],"MFIs":[244,261,295],"CD38;":[246],"CD20;":[247],"CD52;":[248],"CD20/CD52":[249],"CD38/CD20/CD52":[251,454],"antigens.":[252],"Results:":[253],"MFI":[254,391,439],"varied":[255],"significantly":[256,371,420],"between":[257,390,449,510],"3":[259],"groups.":[260],"449":[263],"\u00b148":[264],"units":[266],"(FU);":[267],"70\u00b122":[268],"158\u00b181":[270],"FU,":[271,301],"HD,":[273,289,309],"respectively.":[278,302,319,339,355,365],"Mean":[279,303,320,431],"32\u00b14;":[284],"51.4\u00b115":[285],"28\u00b18":[287],"CLL,":[292],"respectively":[293],"62\u00b114;":[297],"19\u00b18":[298],"35\u00b114":[300],"co-expression":[305],"CD20+CD52":[307,419,496,521],"26\u00b13;":[315],"31\u00b113;":[316],"48\u00b121,":[318],"apoptosis":[321,343,379,393,422,456,481,499,516],"HD":[329],"25,000\u00b118,000;":[331],"23,000\u00b121,000":[332],"47,000\u00b123,000":[334],"apoptotic":[335],"cells/ug":[336],"Ab/24h":[337],"treatment,":[338],"For":[340,356],"17,000\u00b116,000;":[351],"20,000\u00b120,000":[352],"25,000\u00b122,000,":[354],"it":[359],"11,000\u00b17,200;":[361],"16,000\u00b17,000":[362],"13,000\u00b119,000,":[364],"more":[372],"sensitive":[373],"CD52+CD20-induced":[378],"than":[380],"(p<0.01).":[385],"Significant":[386],"correlation":[387,446,507],"(R=0.5;":[399],"p=0.02),":[400],"(R":[404,428],"=0.65;":[405],"p=0.003)":[406],"(R=0.6;":[414],"p=0.004).":[415],"=0.59;":[429],"p<0.02).":[430],"43\u00b122":[437],"57\u00b136":[441],"FU.":[442],"Most":[443],"importantly,":[444],"no":[445],"found":[448,509],"CD20+":[462],"Abs.":[464,522],"Conclusions:":[465],"1.":[466],"(%;":[471],"MFI)":[472],"are":[477],"important":[478],"Ab-induced":[480],"2.":[492],"increases":[498],"3.":[505],"No":[506],"4.":[523],"Prescreening":[524],"is":[532],"recommended":[533],"optimal":[535],"therapy.":[539]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-10-28T00:00:00"}